Acute Kidney Injury Associated with Linagliptin

Acute Kidney Injury Associated with Linagliptin

Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of type 2 diabetes mellitus. About 5% of linagliptin is eliminated by the kidneys and no dose adjustment is recommended in kidney impairment. We report a first case of linagliptin-associated acute kidney i...

Full description

Saved in:
Bibliographic Details
Main Authors: Deepak K. Nandikanti, Elvira O. Gosmanova, Aidar R. Gosmanov
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/5695641
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items